Hypervision Surgical secures a £17m Series A led by Heal Capital to equip surgeons with next-gen tissue imaging

Hypervision Surgical develops imaging technology that provides real-time insights into tissue during surgery. Its platform enables surgeons to assess tissue physiology beyond what is visible to the human eye, supporting intraoperative decision-making.